788 FIRST IN HUMAN TRIAL OF IMU-856, AN ORALLY AVAILABLE EPIGENETIC MODULATOR OF BARRIER REGENERATION FOR THE TREATMENT OF CELIAC DISEASE
| Autor: | Buriánek, Franziska, Pröbstl, Doris, Peelen, Evelyn, Fonseca, Juliano, Schreieck, Amelie, Wirth, Martina, Kehler, Inge, Vitt, Daniel, Kohlhof, Hella, Muehler, Andreas |
|---|---|
| Zdroj: | In Gastroenterology 18-21 May 2024 166(5) Supplement:S |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|